The Journal of Neuroscience, June 3, 2009, 29(22):7124-7136; doi:10.1523/JNEUROSCI.1090-09.2009
Previous Article | Next Article 
Neurobiology of Disease
PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors
Atheir I. Abbas,1 *
Prem N. Yadav,2 *
Wei-Dong Yao,7,8,9,10
Margaret I. Arbuckle,11
Seth G. N. Grant,11,12
Marc G. Caron,7,8,9 and
Bryan L. Roth1,2,3,4,5,6
1Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, Departments of 2Pharmacology, 3Medicinal Chemistry, and 4Psychiatry, 5Lineberger Cancer Center, and 6National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina, Chapel Hill, North Carolina 27599, Departments of 7Cell Biology, 8Medicine, and 9Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, 10Department of Psychiatry, Division of Neurosciences, New England Primate Research Center, Harvard Medical School, Boston, Massachusetts 02115, 11Division of Neuroscience, University of Edinburgh, Edinburgh EH8 9JZ, United Kingdom, and 12Genes to Cognition Programme, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom
Correspondence should be addressed to Dr. Bryan L. Roth, Department of Pharmacology, University of North Carolina, 4009 Genetics Medicine Building, CB#7365, Chapel Hill, NC 27599-7365. Email: bryan_roth{at}med.unc.edu
Here, we report that postsynaptic density protein of 95 kDa (PSD-95), a postsynaptic density scaffolding protein, classically conceptualized as being essential for the regulation of ionotropic glutamatergic signaling at the postsynaptic membrane, plays an unanticipated and essential role in mediating the actions of hallucinogens and atypical antipsychotic drugs at 5-HT2A and 5-HT2C serotonergic G-protein-coupled receptors. We show that PSD-95 is crucial for normal 5-HT2A and 5-HT2C expression in vivo and that PSD-95 maintains normal receptor expression by promoting apical dendritic targeting and stabilizing receptor turnover in vivo. Significantly, 5-HT2A- and 5-HT2C-mediated downstream signaling is impaired in PSD-95null mice, and the 5-HT2A-mediated head-twitch response is abnormal. Furthermore, the ability of 5-HT2A inverse agonists to normalize behavioral changes induced by glutamate receptor antagonists is abolished in the absence of PSD-95 in vivo. These results demonstrate that PSD-95, in addition to the well known role it plays in scaffolding macromolecular glutamatergic signaling complexes, profoundly modulates metabotropic 5-HT2A and 5-HT2C receptor function.
Received March 5, 2009;
revised April 13, 2009;
accepted April 23, 2009.
Correspondence should be addressed to Dr. Bryan L. Roth, Department of Pharmacology, University of North Carolina, 4009 Genetics Medicine Building, CB#7365, Chapel Hill, NC 27599-7365. Email: bryan_roth{at}med.unc.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2009 29: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Jones, D. P. Srivastava, J. A. Allen, R. T. Strachan, B. L. Roth, and P. Penzes
Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling
PNAS,
November 17, 2009;
106(46):
19575 - 19580.
[Abstract]
[Full Text]
[PDF]
|
 |
|